Curis (CRIS) Free Cash Flow (2010 - 2026)
Curis (CRIS) reported Free Cash Flow of -$9.0 million for Q1 2026, down 24.1% on a YoY basis from -$11.9 million in Q1 2025, and down 41.27% quarter-over-quarter from -$6.4 million in Q4 2025.
Curis (CRIS) Free Cash Flow (2010 - 2026) Analysis & Trends
Curis has reported Free Cash Flow for 17 years, with the latest figure at -$9.0 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 24.1% year-over-year to -$9.0 million; the trailing twelve-month figure through Mar 2026 stood at -$28.9 million (up 13.8% YoY), and the FY2025 full-year result was -$27.2 million, up 31.25% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$9.0 million, down from -$6.4 million in the prior quarter.
- The five-year high for Free Cash Flow was -$5.6 million in Q3 2025, with the low at -$16.8 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$9.9 million across 5 years, with a median of -$9.3 million in 2024.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 87.49% — and 2025, when it surged 45.19%.
- Curis' Free Cash Flow stood at -$12.3 million in 2022, then increased by 16.97% to -$10.2 million in 2023, then increased by 9.09% to -$9.3 million in 2024, then surged by 31.2% to -$6.4 million in 2025, then slumped by 41.27% to -$9.0 million in 2026.
- The last three Free Cash Flow figures came in at -$9.0 million (Q1 2026), -$6.4 million (Q4 2025), and -$5.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 63,220.27 |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | -9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.00 Mn |
| Mar 31, 2026 | -9.00 Mn |
| Dec 31, 2025 | -6.37 Mn |
| Dec 31, 2025 | -6.37 Mn |
| Sep 30, 2025 | -5.57 Mn |
| Sep 30, 2025 | -5.57 Mn |
| Jun 30, 2025 | -8.01 Mn |
| Jun 30, 2025 | -8.01 Mn |
| Mar 31, 2025 | -7.25 Mn |
| Mar 31, 2025 | -7.25 Mn |
| Dec 31, 2024 | -9.26 Mn |
| Dec 31, 2024 | -9.26 Mn |
| Sep 30, 2024 | -5.94 Mn |
| Sep 30, 2024 | -5.94 Mn |
| Jun 30, 2024 | -11.14 Mn |
| Jun 30, 2024 | -11.14 Mn |
| Mar 31, 2024 | -13.23 Mn |
| Mar 31, 2024 | -13.23 Mn |
| Dec 31, 2023 | -10.19 Mn |
| Dec 31, 2023 | -10.19 Mn |